Transplantation for ITP and Evans syndrome 11
39 Reston JT, Uhl S, Treadwell JR, et al.:
Autologous hematopoietic cell trans-
plantation for multiple sclerosis: a sys-
tematic review. Multiple Sclerosis
2011; 17:204–213
40 Marmont du Haut Champ AM: He-
matopoietic stem cell transplantation
for systemic lupus erythematosus (Re-
view). Clin Dev Immunol 2012;
2012:380391
41 Van Laar JM, Sullivan K: Stem cell
transplantation in systemic sclerosis
(Review). Curr Opin Rheumatol 2013;
25:719–725
42 Farge D, Labopin M, Tyndall A, et al.:
Autologous hematopoietic stem cell
transplantation for autoimmune dis-
eases: an observational study on
12 years’ experience from the Euro-
pean Group for Blood and Marrow
Transplantation Working Party on
Autoimmune Diseases. Haematologica
2010; 95:284–292
43 Gratwohl A, Passweg J, Bocelli-Tyn-
dall C, et al.: Autologous hematopoi-
etic stem cell transplantation for
autoimmune diseases. Bone Marrow
Transplant 2005; 35:869–879
44 Daikeler T, H€ ugle T, Farge D, et al.:
Allogeneic hematopoietic SCT for
patients with autoimmune diseases.
Bone Marrow Transplant 2009; 44:27–
33 [Erratum appears in Bone Marrow
Transplant. 2009 Jul;44(1):67]
45 Lim SH, Kell J, al-Sabah A, et al.: Pe-
ripheral blood stem-cell transplanta-
tion for refractory autoimmune
thrombocytopenic purpura. Lancet
1997; 349:475
46 Skoda RC, Tichelli A, Tyndall A, et al.:
Autologous peripheral blood stem cell
transplantation in a patient with
© 2015 International Society of Blood Transfusion
Vox Sanguinis (2016) 110, 5–11
chronic autoimmune thrombocytope-
nia. Br J Haematol 1997; 99:56–57
47 Huhn RD, Fogarty PF, Nakamura R,
et al.: High-dose cyclophosphamide
with autologous lymphocyte-depleted
peripheral blood stem cell (PBSC) sup-
port for treatment of refractory
chronic autoimmune thrombocytope-
nia. Blood 2003; 101:71–77
48 Marmont AM, Gualandi F, Occhini D,
et al.: Catastrophic relapse of Evans
syndrome five years after allogeneic
BMT notwithstanding full donor chi-
merism. Terminal hemolytic-uremic
syndrome. Autoimmunity 2006;
39:505–511
49 Musso M, Porretto F, Crescimanno A,
et al.: Donor lymphocyte infusions for
refractory pure red cell aplasia relaps-
ing after both autologous and non-
myeloablative allogeneic peripheral
stem cell transplantation. Bone Mar-
row Transplant 2004; 33:769–771
50 Urban C, Lackner H, Sovinz P, et al.:
Successful unrelated cord blood trans-
plantation in a 7-year-old boy with
Evans syndrome refractory to
immunosuppression and double autol-
ogous stem cell transplantation. Eur J
Haematol 2006; 76:526–530
51 Caselli D, Farruggia P, Trizzino A,
et al.: Split chimerism may be enough
to cure Evans syndrome. Bone Marrow
Transplant 2006; 38:311
52 Passweg JR, Rabusin M, Musso M,
et al: Haematopoetic stem cell trans-
plantation for refractory autoimmune
cytopenia. Br J Haematol 2004;
125:749–755
53 Passweg JR, Rabusin M: Hematopoetic
stem cell transplantation for immune
thrombocytopenia and other refractory
autoimmune cytopenias. Autoimmu-
nity 2008; 41:660–665
54 Rabusin M, Snowden JA, Veys P,
et al.: Long-term outcomes of
hematopoietic stem cell transplanta-
tion for severe treatment-resistant
autoimmune cytopenia in children.
Biol Blood Marrow Transplant 2013;
19:666–669
55 Snowden JA, Saccardi R, Allez M,
et al.: Haematopoietic SCT in severe
autoimmune diseaes: updated guideli-
nes of the European Group for Blood
and Marrow Transplantation. Bone
Marrow Transplant 2012; 47:770–790
56 Pasquini MC, Voltarelli J, Atkins HL,
et al.: Transplantation for autoimmune
diseases in north and South America:
a report of the Center for International
Blood and Marrow Transplant
Research. Biol Blood Marrow Trans-
plant 2012; 18:1471–1478
57 McMillan R, Durette C: Long-term out-
comes in adults with chronic ITP after
splenectomy failure. Blood 2004;
104:956–960
58 Martino R, Sureda A, Brunet S: Pe-
ripheral blood stem cell mobilization
in refractory autoimmune Evans syn-
drome: a cautionary case report. Bone
Marrow Transplant 1997; 20:521
59 Sorror ML, Maris MB, Storb R, et al.:
Hematopoietic cell transplantation
(HCT)-specific comorbidity index: a
new tool for risk assessment before
allogeneic HCT. Blood 2005;
106:2912–2919
60 Provan D, Stasi R, Newland AC, et al.:
International consensus report on the
investigation and management of
primary immune thrombocytopenia
(Review). Blood 2010; 115:168–186